Metabolic syndrome vs. its components for prediction of cardiovascular mortality: A cohort study in Chinese elderly adults

Journal of Geriatric Cardiology

Volumn 9, Issue 2, 2012, Pages 123-129

  Sun, Dong Ling ^a   Wang, Jian Hua ^a   Jiang, Bin ^a   Li, Liang Shou ^b   Li, Lan Sun ^b   Wu, Lei ^b   Wu, Hai Yun ^a   He, Yao ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cardiovascular disease; Chinese adults; Cohort study; Metabolic syndrome

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHINESE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ELDERLY CARE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; HYPERTENSION; MACHINE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREDICTION; PREDICTIVE VALUE; PREVALENCE; PROPORTIONAL HAZARDS MODEL;

EID: 84866240849     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1263.2012.01172     Document Type: Article

References (19)

1. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28: 1769-1778. (Pubitemid 40923091)
2. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006; 119: 812-819. (Pubitemid 44415613)
3. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-414. (Pubitemid 46135879)
4. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010; 56: 1113-1132.
5. Ravaglia G, Forti P, Maioli F, et al. Metabolic Syndrome: prevalence and prediction of mortality in elderly individuals. Diabetes Care 2006; 29: 2471-2476. (Pubitemid 44912255)
6. Wang J, Ruotsalainen S, Moilanen L, et al. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 2007; 28: 857-864. (Pubitemid 47351113)
7. He Y, Jiang B, Wang J, et al. Prevalence of the Metabolic Syndrome and its Relation to Cardiovascular Disease in an Elderly Chinese Population. J Am Coll Cardiol 2006; 47: 1588-1594.
8. Zambon S, Zanoni S, Romanato G, et al. Metabolic syndrome and all-cause and cardiovascular mortality in an Italian elderly population: the Progetto Veneto Anziani (Pro.V.A.) Study. Diabetes Care 2009; 32: 153-159.
9. Sattar N, McConnachie A, Shaper AG, et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 2008; 371: 1927-1935.
10. Mozaffarian D, Kamineni A, Prineas RJ, et al. Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med 2008; 168: 969-978. (Pubitemid 351679637)
11. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
12. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
13. Marsland AL, McCaffery JM, Muldoon MF, et al. Systemic inflammation and the metabolic syndrome among middle-aged community volunteers. Metabolism 2010; 59: 1801-1808.
14. Mizuno T, Matsui H, Imamura A, et al. Insulin resistance increases circulating malondialdehyde-modified LDL and impairs endothelial function in healthy young men. Int J Cardiol 2004; 97: 455-461. (Pubitemid 39550695)
15. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006; 332: 73-78.
16. De Silva NM, Freathy RM, Palmer TM, et al. Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance. Diabetes 2011; 60: 1008-1018.
17. McGee DL. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 2005; 15: 87-97. (Pubitemid 40126638)
18. Woodward M, Tunstall-Pedoe H. The metabolic syndrome is not a sensible tool for predicting the risk of coronary heart disease. Eur J Cardiovasc Prev Rehabil 2009; 16: 210-214.
19. Knuiman MW, Hung J, Divitini ML, et al. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study. Eur J Cardiovasc Prev Rehabil 2009; 16: 235-241.